Guide to FDA 510(k) Labeling and Instructions for Use (IFU)

Your device labeling is not just marketing material; it's a critical component of your 510(k) submission that is legally binding and heavily scrutinized by the FDA. Inconsistent or incomplete labeling is a common reason for an Additional Information request. All labeling must comply with FDA regulations, primarily 21 CFR 801.

What Does "Labeling" Include?

The term "labeling" is broad and covers all written, printed, or graphic matter accompanying your device. For a 510(k), you must submit a complete, final draft of all labeling, including:

• check_circle
  Device Labels: The physical labels affixed to the device itself and its packaging.
• check_circle
  Instructions for Use (IFU): A detailed booklet or manual explaining how to use the device safely and effectively. This is the most extensive part of the labeling.
• check_circle
  Package Inserts: Any additional documentation included in the packaging.
• check_circle
  Patient Labeling: If applicable, simplified instructions intended for the patient.

21 CFR 801: The Foundation of Device Labeling

FDA labeling requirements are codified in 21 CFR Part 801. Key requirements include: the device name and intended use; the name and place of the manufacturer, packer, or distributor; adequate directions for use; and any applicable warnings or precautions. For prescription devices, the labeling must state that the device is restricted to sale by or on the order of a licensed practitioner. Unique Device Identification (UDI) requirements under 21 CFR 830 and 801.20 also apply—your device and its packaging must bear the UDI in the format specified by the FDA.

IFU Structure and Content

A well-structured IFU typically includes: Indications for Use (must match your 510(k) exactly); Contraindications; Warnings and Precautions; Device Description; Instructions for Use (step-by-step); Storage and Handling; and any required symbols per ISO 15223-1. The FDA expects the IFU to be written at an appropriate reading level for the intended user. Inconsistent terminology between your IFU and other submission sections is a common cause of AI requests—use the same phrasing for indications, intended use, and device description throughout.

References & Citations

This guide cites the following FDA and regulatory sources.

1. 21 CFR Part 801 — Labeling (eCFR)
2. FDA: Unique Device Identification (UDI) System
3. FDA: Device Labeling

Key Requirements for the Instructions for Use (IFU)

The IFU is a comprehensive technical document. It must be clear, concise, and written for the intended user (e.g., a surgeon, a lab technician, a patient).

• fact_check
  Indications for Use: Must be an *exact* match to the Indications for Use statement submitted elsewhere in your 510(k).
• fact_check
  Device Description: A brief explanation of the device and its principle of operation.
• fact_check
  Contraindications: A clear statement of situations where the device should not be used.
• fact_check
  Warnings and Precautions: Warnings describe potential serious adverse events, while precautions describe measures to take to avoid device malfunction or damage.
• fact_check
  Step-by-Step Instructions: Detailed, unambiguous directions for setup, use, cleaning, and storage.
• fact_check
  Technical Specifications: Any relevant performance specifications the user needs to be aware of.

The Unique Device Identification (UDI) System

Your device label must comply with the FDA's UDI system. The UDI is a unique numeric or alphanumeric code that consists of two parts:

• qr_code_2
  Device Identifier (DI): A mandatory, fixed portion that identifies the labeler and the specific version or model of a device.
• production_quantity_limits
  Production Identifier (PI): A conditional, variable portion that can include the lot/batch number, serial number, expiration date, or manufacturing date.

The UDI must be presented in both a plain-text version and a machine-readable format (e.g., a barcode or QR code). Your 510(k) submission must include a draft label showing the UDI in its final format.